TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies

Mutations in the gene for fibrillin‐1 (FBN1) cause Marfan syndrome (MFS), an autosomal dominant heritable disorder of connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular system. FBN1 mutations have also been identified in a series of related disorders of connective tissue collectively termed type‐1 fibrillinopathies. We have developed temperature‐gradient gel electrophoresis (TGGE) assays for all 65 FBN1 exons, screened 126 individuals with MFS, other type‐1 fibrillinopathies, and other potentially related disorders of connective tissue for FBN1 mutations, and identified a total of 53 mutations, of which 33 are described here for the first time. Several mutations were identified in individuals with fibrillinopathies other than classic Marfan syndrome, including aneurysm of the ascending aorta with only minor skeletal anomalies, and several individuals with only skeletal and ocular involvement. The mutation detection rate in this study was 42% overall, but was only 12% in individuals not fulfilling the diagnostic criteria for MFS, suggesting that clinical overdiagnosis is one reason for the low detection rate observed for FBN1 mutation analysis. Hum Mutat 20:197–208, 2002. © 2002 Wiley‐Liss, Inc.

[1]  C. Junien,et al.  Demonstration of the recurrence of Marfan-like skeletal and cardiovascular manifestations due to germline mosaicism for an FBN1 mutation. , 1999, American Journal of Human Genetics.

[2]  H. Dietz,et al.  Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome , 1996, Nature Genetics.

[3]  R E Pyeritz,et al.  Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. , 1995, American journal of human genetics.

[4]  P. Robinson,et al.  A novel de novo mutation in exon 14 of the fibrillin-1 gene associated with delayed secretion of fibrillin in a patient with a mild Marfan phenotype , 1997, Human Genetics.

[5]  C. Detter,et al.  A novel mutation in the neonatal region of the fibrillin (FBN) 1 gene associated with a classical phenotype of Marfan syndrome (MfS) , 1998, Human mutation.

[6]  P. Robinson,et al.  Bipolar clamping improves the sensitivity of mutation detection by temperature gradient gel electrophoresis , 1998, Electrophoresis.

[7]  E. Boerwinkle,et al.  Familial Thoracic Aortic Aneurysms and Dissections: Genetic Heterogeneity With a Major Locus Mapping to 5q13-14 , 2001, Circulation.

[8]  P. Robinson,et al.  Mutations of FBN1 and genotype–phenotype correlations in Marfan syndrome and related fibrillinopathies , 2002, Human mutation.

[9]  R E Pyeritz,et al.  Revised diagnostic criteria for the Marfan syndrome. , 1996, American journal of medical genetics.

[10]  F. Spencer,et al.  Revised genomic organization of FBN1 and significance for regulated gene expression. , 1999, Genomics.

[11]  P. Robinson,et al.  Human Genome and Diseases:¶The molecular pathogenesis of the Marfan syndrome , 2001, Cellular and Molecular Life Sciences CMLS.

[12]  E. Girodon,et al.  Psoralen-modified oligonucleotide primers improve detection of mutations by denaturing gradient gel electrophoresis and provide an alternative to GC-clamping. , 1993, Human molecular genetics.

[13]  Y. Okita,et al.  Eight novel mutations of the FBN1 gene found in Japanese patients with Marfan syndrome , 2001, Human mutation.

[14]  C. Hayward,et al.  Mutation screening of all 65 exons of the fibrillin‐1 gene in 60 patients with Marfan syndrome: Report of 12 novel mutations , 1997, Human mutation.

[15]  Hanns-Georg Klein,et al.  Marfan Database (third edition): new mutations and new routines for the software , 1998, Nucleic Acids Res..

[16]  U. Francke,et al.  Mutation screening of complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains. , 1993, Human molecular genetics.

[17]  R. Shprintzen,et al.  Shprintzen-Goldberg syndrome: a clinical analysis. , 1998, American journal of medical genetics.

[18]  L. Peltonen,et al.  Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in Marfan syndrome and related conditions , 2002, Journal of medical genetics.

[19]  L. Peltonen,et al.  Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome , 1994, Nature Genetics.

[20]  P. Oefner,et al.  Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders. , 1997, Genetic testing.

[21]  Catherine Boileau,et al.  Evaluation and application of denaturing HPLC for mutation detection in Marfan syndrome: Identification of 20 novel mutations and two novel polymorphisms in the FBN1 gene , 2002, Human mutation.

[22]  P. Handford,et al.  Solution structure of the transforming growth factor β‐binding protein‐like module, a domain associated with matrix fibrils , 1997, The EMBO journal.

[23]  U. Francke,et al.  Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome. , 1996, Human molecular genetics.

[24]  U. Francke,et al.  Multi-exon deletions of the FBN1 gene in Marfan syndrome , 2001, BMC Medical Genetics.

[25]  M. Passos-Bueno,et al.  Identification of 8 new mutations in Brazilian families with Marfan syndrome , 1999, Human mutation.

[26]  P. Robinson,et al.  The molecular genetics of Marfan syndrome and related microfibrillopathies , 2000, Journal of medical genetics.

[27]  U. Francke,et al.  A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. , 1995, American journal of human genetics.

[28]  C. Hayward,et al.  Fibrillin‐1 mutations in Marfan syndrome and other type‐1 fibrillinopathies , 1997, Human mutation.

[29]  D. Sillence,et al.  International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. , 1988, American journal of medical genetics.

[30]  J. Coselli,et al.  Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. , 1996, Circulation.

[31]  J. Weissenbach,et al.  A second locus for Marfan syndrome maps to chromosome 3p24.2–p25 , 1994, Nature Genetics.

[32]  L. Peltonen,et al.  Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Robinson,et al.  Clustering of mutations associated with mild Marfan-like phenotypes in the 3' region of FBN1 suggests a potential genotype-phenotype correlation. , 2000, American journal of medical genetics.

[34]  R. Pyeritz.  The Marfan syndrome. , 1986, American family physician.

[35]  Yoriko Watanabe,et al.  P1148A in fibrillin‐1 is not a mutation leading to Shprintzen‐Goldberg syndrome , 1997, Human mutation.

[36]  L. Peltonen,et al.  A point mutation creating an extra N-glycosylation site in fibrillin-1 results in neonatal Marfan syndrome. , 1996, Genomics.

[37]  A. De Paepe,et al.  Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome. , 2001, Archives of internal medicine.

[38]  Flemming Skovby,et al.  Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype–phenotype correlations in FBN1 exons 24–40 , 2001, European Journal of Human Genetics.

[39]  P. Robinson,et al.  Two recurrent nonsense mutations and a 4 bp deletion in a quasi-symmetric element in exon 37 of the NF1 gene , 1995, Human Genetics.

[40]  D. Milewicz,et al.  Identification of a Chromosome 11q23.2-q24 Locus for Familial Aortic Aneurysm Disease, a Genetically Heterogeneous Disorder , 2001, Circulation.

[41]  P. Robinson,et al.  Novel exon skipping mutation in the fibrillin‐1 gene: Two ‘hot spots’ for the neonatal Marfan syndrome , 1999, Clinical genetics.

[42]  H. Dietz,et al.  A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. , 1994, The New England journal of medicine.

[43]  H. Yoo,et al.  Six novel mutations of the fibrillin‐1 gene in Korean patients with Marfan syndrome , 2000, Pediatrics international : official journal of the Japan Pediatric Society.

[44]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.

[45]  T. Toner,et al.  Enzymatic mutation detection (EMD™) of novel mutations (R565X and R1523X) in the FBN1 gene of patients with Marfan syndrome using T4 endonuclease VII , 2000, Human mutation.

[46]  F. Ramirez.  Fibrillln mutations in Marfan syndrome and related phenotypes. , 1996, Current opinion in genetics & development.

[47]  J. Graham,et al.  P1148A in fibrillin-1 is not a mutation anymore , 1997, Nature Genetics.

[48]  A. Child,et al.  Erratum: Detection of six novel FBN1 mutations in British patients affected by Marfan syndrome , 2001, Human mutation.

[49]  D. Milewicz,et al.  Clustering of FBN2 mutations in patients with congenital contractural arachnodactyly indicates an important role of the domains encoded by exons 24 through 34 during human development. , 1998, American journal of medical genetics.

[50]  I. Campbell,et al.  Solution Structure of a Pair of Calcium-Binding Epidermal Growth Factor-like Domains: Implications for the Marfan Syndrome and Other Genetic Disorders , 1996, Cell.